Vendor, Lawrence, KS
Virovax LLC
UEI H9QWJVY8MT78, CAGE 85XH0
1 award and -$468 obligated between September 9, 2024 and February 12, 2025, 100% under full and open competition, against 17.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$468 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93018C00049Definitive Contract, September 9, 2024, Full and Open Competition, 17 offers | National Institutes of Health NiaidNational Institutes of Health | Adjuvant Development ProgramNAICS 541714, PSC AN11 | -$468 |
- Places of performance
- Kansas
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 2 across 1 awards